𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Newer antifungal agents

✍ Scribed by Michael Bigby

Book ID
117850103
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
52 KB
Volume
49
Category
Article
ISSN
1097-6787

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Newer antifungal agents
Newer antifungal agents
✍ Walid Abuhammour; Eyassu Habte-Gaber πŸ“‚ Article πŸ“… 2004 πŸ› Springer-Verlag 🌐 English βš– 695 KB
Newer antifungal agents
Newer antifungal agents
✍ TΓΌrel, Γ–zden πŸ“‚ Article πŸ“… 2011 πŸ› Expert Reviews 🌐 English βš– 321 KB
Clinical indications for newer antifunga
Clinical indications for newer antifungal agents
✍ Nina Naeger-Murphy; James C. Pile πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 118 KB

## Abstract Recent years have seen the release of multiple new systemic antifungal agents, significantly increasing options for the treatment of most serious fungal infections. Newly available drugs include those in the echinocandin class, including caspofungin, micafungin, and anidulafungin, as we

Drug interactions of the newer oral anti
Drug interactions of the newer oral antifungal agents
✍ Katz πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 111 KB

The newer oral antifungal agents, such as fluconazole, itraconazole and terbinafine, are generally both effective and well tolerated in the management of widespread or resistant dermatomycoses such as onychomycosis. However, these agents differ markedly in their potential to cause clinically signifi